Wilbur Ross’s SPAC Is Said to Near Merger With Biotech Aprinoia

Aprinoia Therapeutics, which is learning medicine for Alzheimer’s and Parkinson’s illnesses, is nearing a deal to go public by means of Wilbur Ross’s blank-check firm, in response to folks with information of the matter.

The take care of Ross Acquisition Corp. II would worth the mixed firm at about $320 million together with debt, mentioned the folks, who requested to not be recognized as a result of the matter is non-public. A deal may very well be introduced as quickly as this week, the folks mentioned.

No remaining resolution has been made and talks might nonetheless fall by means of, the folks added. Representatives for Ross and Aprinoia declined to …